GME751 (pembrolizumab biosimilar) - Sandoz
Yervoy (ipilimumab) - BMS
ABP 206 (nivolumab biosimilar) - Amgen
Arfleyda (pembrolizumab biosimilar) - R-Pharm
Opdivo (nivolumab) - Ono Pharma, BMS
QL2107 (pembrolizumab biosimilar) - Qilu Pharma
Cdactin-O (CBM588) - Osel, Miyarisan
BCD-263 (nivolumab biosimilar) - Biocad
Lenvima (lenvatinib) - Eisai, Merck (MSD)
Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) - BMS, Ono Pharma
Keytruda (pembrolizumab) - Merck (MSD)
Cabometyx (cabozantinib tablet) - Exelixis
axitinib - Generic mfg.
http://clinicaltrials.gov/ct2/show/NCT07383441
 
Feb 4, 2026
 
Next